Natural Product: NPC273189

Natural Product IDNPC273189
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Clethroidoside D
IUPAC Name n.a.
Synonyms Clethroidoside D
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1927849
PubChem CID 56598062
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LXYNMISGVPYMHU-LGZUVIOGSA-N
Standard InCHI InChI=1S/C52H84O21/c1-46(2)14-15-51-22-67-52(29(51)16-46)13-9-28-48(5)11-10-31(47(3,4)27(48)8-12-49(28,6)50(52,7)17-30(51)56)71-44-40(73-43-39(64)36(61)33(58)24(18-53)68-43)35(60)26(21-66-44)70-45-41(37(62)34(59)25(19-54)69-45)72-42-38(63)32(57)23(55)20-65-42/h23-29,31-45,53-55,57-64H,8-22H2,1-7H3/t23-,24-,25-,26+,27+,28-,29-,31+,32+,33-,34-,35+,36+,37+,38-,39-,40-,41-,42+,43+,44+,45+,48+,49-,50+,51-,52+/m1/s1
SMILES CC1(C)CC[C@@]23CO[C@@]4(CC[C@@H]5[C@@]6(C)CC[C@@H](C(C)(C)[C@@H]6CC[C@@]5(C)[C@]4(C)CC3=O)O[C@H]3[C@@H]([C@H]([C@H](CO3)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)[C@@H]2C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1044.55 Volume:   1004.341
?
Van der Waals volume.
Dense:   1.04 LogP:   0.623
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.564
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.884
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   10.0 Rigid Bonds:   54.0
TPSA:   322.67
?
Topological Polar Surface Area.
H-Bond Acceptor:   21.0
H-Bond Donor:   11.0 Rings:   10.0
Heavy Atoms:   21.0

MedChem Properties

QED Drug-Likeness Score:   0.119 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.958 Fsp3:   0.981
MCE-18:   282.35
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.948 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.002
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.003
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.218 Promiscuous compounds:   0.054

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.383 MDCK Permeability:   -5.219
Pgp-inhibitor:   0.0 Pgp-substrate:   0.091
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.077
20% Bioavailability (F20%):   0.086 30% Bioavailability (F30%):   0.929
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.411 MRP1:   0.013
Plasma Protein Binding (PPB):   73.736% Volume Distribution (VD):   -0.461
Fu: 17.733%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.007
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.227 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.02 CYP3A4-substrate:   0.051
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.008
HLM stability:   0.048
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  -0.157 Half-life (T1/2):  2.999

ADMET: Toxicity

hERG Blockers:  0.002 hERG Blockers (10um):  0.003
Human Hepatotoxicity (H-HT):  0.772 Drug-induced Liver Injury (DILI):  0.885
AMES Toxicity:  0.985 Rat Oral Acute Toxicity:  0.001
Maximum Recommended Daily Dose:  0.001 Skin Sensitization:  1.0
Carcinogencity:  0.049 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.0
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  1.0
Hematotoxicity:  0.73 Drug-induced Nephrotoxicity:  0.994
Genotoxicity:  0.131 RPMI-8226 Immunitoxicity:  0.258
A549 Cytotoxicity:  0.789 Hek293 Cytotoxicity:  0.363
BCF:   1.187
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.464
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.852
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.974
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21278 Lysimachia clethroides Species Primulaceae Eukaryota n.a. aerial part n.a. PMID[21928797]
NPO21278 Lysimachia clethroides Species Primulaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO21278 Lysimachia clethroides Species Primulaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21278 Lysimachia clethroides Species Primulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell line HT-29 Homo sapiens IC50 = 1980.0 nM PMID[21928797]
NPT65 Cell line HepG2 Homo sapiens IC50 = 1730.0 nM PMID[21928797]
NPT547 Cell line BGC-823 Homo sapiens IC50 = 1360.0 nM PMID[21928797]
NPT81 Cell line A549 Homo sapiens IC50 = 2360.0 nM PMID[21928797]
NPT1083 Cell line A-375 Homo sapiens IC50 = 1910.0 nM PMID[21928797]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC273189 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9091 High Similarity NPC184805
0.7981 Intermediate Similarity NPC77717
0.7876 Intermediate Similarity NPC471430
0.7788 Intermediate Similarity NPC267637
0.75 Intermediate Similarity NPC470622
0.7431 Intermediate Similarity NPC138219
0.7431 Intermediate Similarity NPC475234
0.7364 Intermediate Similarity NPC471375
0.7297 Intermediate Similarity NPC51579
0.7248 Intermediate Similarity NPC87393
0.7222 Intermediate Similarity NPC253611
0.7222 Intermediate Similarity NPC488782
0.7091 Intermediate Similarity NPC471373
0.7054 Intermediate Similarity NPC473688
0.6952 Remote Similarity NPC18724
0.6842 Remote Similarity NPC209798
0.6838 Remote Similarity NPC471425
0.6814 Remote Similarity NPC475630
0.678 Remote Similarity NPC189575
0.6762 Remote Similarity NPC80640
0.6754 Remote Similarity NPC471374
0.6697 Remote Similarity NPC323231
0.6695 Remote Similarity NPC66513
0.6637 Remote Similarity NPC40716
0.6612 Remote Similarity NPC106701
0.661 Remote Similarity NPC262567
0.66 Remote Similarity NPC80417
0.6549 Remote Similarity NPC267238
0.6525 Remote Similarity NPC205129
0.6423 Remote Similarity NPC471426
0.6393 Remote Similarity NPC231566
0.6364 Remote Similarity NPC158051
0.6348 Remote Similarity NPC148593
0.6311 Remote Similarity NPC471429
0.629 Remote Similarity NPC471427
0.6273 Remote Similarity NPC224003
0.6261 Remote Similarity NPC207693
0.6228 Remote Similarity NPC119628
0.621 Remote Similarity NPC22709
0.6207 Remote Similarity NPC157571
0.6195 Remote Similarity NPC171741
0.6167 Remote Similarity NPC126753
0.6032 Remote Similarity NPC471424
0.5938 Remote Similarity NPC471431
0.5833 Remote Similarity NPC609281
0.582 Remote Similarity NPC607904
0.5763 Remote Similarity NPC158367
0.5714 Remote Similarity NPC470623
0.5691 Remote Similarity NPC610461
0.5667 Remote Similarity NPC606145
0.5573 Remote Similarity NPC471626
0.5565 Remote Similarity NPC610204
0.5528 Remote Similarity NPC606553
0.5489 Remote Similarity NPC471428
0.5433 Remote Similarity NPC603137
0.5433 Remote Similarity NPC609305
0.536 Remote Similarity NPC185466
0.5126 Remote Similarity NPC469946

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC273189 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data